PortfoliosLab logoPortfoliosLab logo
FTK vs. AMLX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

FTK vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Flotek Industries, Inc. (FTK) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

FTK vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
FTK
Flotek Industries, Inc.
-1.51%80.80%143.11%-41.67%3.70%
AMLX
Amylyx Pharmaceuticals, Inc.
15.07%219.58%-74.32%-60.16%104.48%

Fundamentals

Market Cap

FTK:

$613.57M

AMLX:

$1.31B

EPS

FTK:

$0.83

AMLX:

-$1.57

PB Ratio

FTK:

5.43

AMLX:

4.31

Total Revenue (TTM)

FTK:

$237.26M

AMLX:

$0.00

Gross Profit (TTM)

FTK:

$59.83M

AMLX:

$0.00

EBITDA (TTM)

FTK:

$26.02M

AMLX:

-$144.16M

Returns By Period

In the year-to-date period, FTK achieves a -1.51% return, which is significantly lower than AMLX's 15.07% return.


FTK

1D
0.18%
1M
10.55%
YTD
-1.51%
6M
16.23%
1Y
103.72%
3Y*
60.04%
5Y*
10.08%
10Y*
-9.17%

AMLX

1D
8.93%
1M
-8.37%
YTD
15.07%
6M
2.28%
1Y
292.66%
3Y*
-22.04%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTK vs. AMLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTK
FTK Risk / Return Rank: 8282
Overall Rank
FTK Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
FTK Sortino Ratio Rank: 8484
Sortino Ratio Rank
FTK Omega Ratio Rank: 7979
Omega Ratio Rank
FTK Calmar Ratio Rank: 8686
Calmar Ratio Rank
FTK Martin Ratio Rank: 8080
Martin Ratio Rank

AMLX
AMLX Risk / Return Rank: 9797
Overall Rank
AMLX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9797
Sortino Ratio Rank
AMLX Omega Ratio Rank: 9494
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9898
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTK vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Flotek Industries, Inc. (FTK) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FTKAMLXDifference

Sharpe ratio

Return per unit of total volatility

1.29

4.03

-2.75

Sortino ratio

Return per unit of downside risk

2.34

4.16

-1.81

Omega ratio

Gain probability vs. loss probability

1.28

1.49

-0.20

Calmar ratio

Return relative to maximum drawdown

3.07

10.02

-6.95

Martin ratio

Return relative to average drawdown

6.01

23.29

-17.28

FTK vs. AMLX - Sharpe Ratio Comparison

The current FTK Sharpe Ratio is 1.29, which is lower than the AMLX Sharpe Ratio of 4.03. The chart below compares the historical Sharpe Ratios of FTK and AMLX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


FTKAMLXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.29

4.03

-2.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

-0.07

+0.02

Correlation

The correlation between FTK and AMLX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

FTK vs. AMLX - Dividend Comparison

Neither FTK nor AMLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

FTK vs. AMLX - Drawdown Comparison

The maximum FTK drawdown since its inception was -99.14%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for FTK and AMLX.


Loading graphics...

Drawdown Indicators


FTKAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-99.14%

-96.04%

-3.10%

Max Drawdown (1Y)

Largest decline over 1 year

-33.29%

-27.93%

-5.36%

Max Drawdown (5Y)

Largest decline over 5 years

-79.07%

Max Drawdown (10Y)

Largest decline over 10 years

-97.24%

Current Drawdown

Current decline from peak

-94.71%

-66.04%

-28.67%

Average Drawdown

Average peak-to-trough decline

-78.26%

-59.24%

-19.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.02%

12.01%

+5.01%

Volatility

FTK vs. AMLX - Volatility Comparison

The current volatility for Flotek Industries, Inc. (FTK) is 16.47%, while Amylyx Pharmaceuticals, Inc. (AMLX) has a volatility of 19.23%. This indicates that FTK experiences smaller price fluctuations and is considered to be less risky than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


FTKAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.47%

19.23%

-2.76%

Volatility (6M)

Calculated over the trailing 6-month period

51.20%

45.20%

+6.00%

Volatility (1Y)

Calculated over the trailing 1-year period

81.07%

73.18%

+7.89%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

84.35%

92.82%

-8.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.20%

92.82%

-5.62%

Financials

FTK vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between Flotek Industries, Inc. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
67.52M
0
(FTK) Total Revenue
(AMLX) Total Revenue
Values in USD except per share items